Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210695 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-11-24 | 2023-12-01 | 211493 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-12-15 | 2024-04-05 | 213556 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-01-26 | 2024-02-16 | 217478 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-03 | 2024-05-24 | 227088 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-10 | 2024-05-24 | 227725 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229401 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-09-05 | 2024-11-01 | 236875 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-12-12 | 2025-01-03 | 245505 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2025-04-17 | 2025-05-02 | 255194 |
| APO-AZATHIOPRINE | 50MG | TABLET | Resolved | 2020-08-26 | 2020-09-14 | 122991 |
| APO-AZITHROMYCIN | 250MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19126 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2017-03-16 | 2017-10-03 | 3083 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2017-11-27 | 2018-04-17 | 30799 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2018-05-15 | 2019-02-21 | 49481 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2020-01-15 | 2020-01-31 | 103362 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2022-01-07 | 2022-03-21 | 152298 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2023-04-21 | 2023-06-23 | 190002 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213573 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |